Search results for " Diet"

showing 10 items of 2950 documents

Endothelial Function in Obese Patients Treated with Bariatric Surgery

2020

Antonio Maria Borzì,1,2,* Carola Buscemi,3,4,* Davide Corleo,3,4 Cristiana Randazzo,3,4 Giuseppe Rosafio,3,4 Gianni Pantuso,5 Silvio Buscemi3,4 1Department of Clinical and Experimental Medicine, Specialization School in Geriatrics, University of Catania, Catania, Italy; 2Specialization School in Geriatrics, Catania, Italy; 3Dipartimento di Promozione della Salute, Materno-Infantile, Medicina Interna e Specialistica di Eccellenza (PROMISE), University of Palermo, Palerno, Italy; 4Unit of Malattie Endocrine, del Ricambio e della Nutrizione, Policlinico University Hospital, Palermo, Italy; 5Dipartimento di Discipline Chirurgiche e Odontostomatologiche (DICHIRONS), Unit of Chirurgia Onco…

obesityendothelial functionRC581-951bariatric surgerySpecialties of internal medicineSettore MED/49 - Scienze Tecniche Dietetiche Applicatemedical nutrition therapyDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy
researchProduct

High-intensity interval training and moderate intensity training with exogenous adenosine counteract development of obesity in rats

2022

Objectives High-Intensity Interval Training (HIIT) and Moderate Intensity Training (MIT) can combat the obesity epidemic. However, studies comparing their effects on obesity show controversial findings regarding weight loss. Adenosine has emerged as a possible, novel therapeutic agent to treat obesity, but more preclinical studies on its efficacy are needed. Therefore, the objectives of this study were to compare the effects of HIIT and MIT on obesity, and further to determine the dose-dependent effects of adenosine on body weight. Equipment and methods We induced obesity in male Wistar rats with high-fat diet (HFD) and monitored development of obesity by comparing the weight to rats on nor…

obesityexercisekuntoliikuntaadenosiiniintervalliharjoitteluModerate Intensity Training (MIT)painonhallintaenergy intakelihavuusOrthopedics and Sports Medicineexogenous adenosineHigh-Intensity Interval Training (HIIT)weight losskoe-eläinmallitisocaloricHigh Fat diet (HFD)
researchProduct

New developments in the pathogenesis of obesity-induced hypertension

2015

Obesity is a disorder that develops from the interaction between genotype and environment involving social, behavioral, cultural, and physiological factors. Obesity increases the risk for type 2 diabetes mellitus, hypertension, cardiovascular disease, cancer, musculoskeletal disorders, chronic kidney and pulmonary disease. Although obesity is clearly associated with an increased prevalence of hypertension, many obese individuals may not develop hypertension. Protecting factors may exist and it is important to understand why obesity is not always related to hypertension. The aim of this review is to highlight the knowledge gap for the association between obesity, hypertension, and potential …

obesityhypertensionPhysiologyAppetiteDiseaseGut floraleptinDiabetes mellitusInternal Medicinemedicinea-MSHAnimalsHumanssaltEpigeneticsExercisesun lightsympathetic nervous systembiologygut microbiotabusiness.industryLeptinpotassiumPotassium DietaryType 2 Diabetes MellitusCancerSodium DietaryProtective Factorsmedicine.diseasebiology.organism_classificationObesityDiabetes Mellitus Type 2Cardiovascular DiseasesImmunologyReceptor Melanocortin Type 4Gene-Environment InteractionCardiology and Cardiovascular Medicinebusiness
researchProduct

Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity

2021

Introduction: The recent global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than 7 million people worldwide and been associated with more than 400,000 deaths. No clear information is known about all the potential risk factors for COVID-19 or what factors adversely influence its clinical course and mortality. Therefore, we analyzed the role of obesity, type 2 diabetes, and hypertension as risk factors for COVID-19. Methods: We identified articles for inclusion by searching PubMed and Google Scholar (last accessed 15 June 2020). Retrospective review of literature. Analysis of epidemiological data co…

obesityhypertensionrisk factordiabeteSARS-CoV-2COVID-19Settore MED/49 - Scienze Tecniche Dietetiche Applicate
researchProduct

Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials

2021

Intermittent fasting has become popular in recent years and is controversially presented as a possible therapeutic adjunct. A bibliographic review of the literature on intermittent fasting and obesity, diabetes, and multiple sclerosis was carried out. The scientific quality of the methodology and the results obtained were evaluated in pairs. Intermittent fasting has beneficial effects on the lipid profile, and it is associated with weight loss and a modification of the distribution of abdominal fat in people with obesity and type 2 diabetes as well as an improvement in the control of glycemic levels. In patients with multiple sclerosis, the data available are too scarce to draw any firm con…

obesitymedicine.medical_specialtyMultiple SclerosisGlycemic ControlReviewType 2 diabeteslaw.inventionRandomized controlled trialWeight losslawDiabetes mellitusIntermittent fastingHumansMedicineTX341-641Intensive care medicineRandomized Controlled Trials as TopicGlycemicNutrition and Dieteticsexercisemedicine.diagnostic_testNutrition. Foods and food supplyintermittent fastingbusiness.industryFastingmedicine.diseaseObesityDiabetes Mellitus Type 2type 2 diabetesmedicine.symptombusinessLipid profileFood ScienceNutrients
researchProduct

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches

2013

Small, dense low density lipoprotein (sdLDL) represents an emerging cardiovascular risk factor, since these particles can be associated with cardiovascular disease (CVD) independently of established risk factors, including plasma lipids. Obese subjects frequently have atherogenic dyslipidaemia, including elevated sdLDL levels, in addition to elevated triglycerides (TG), very low density lipoprotein (VLDL) and apolipoprotein-B, as well as decreased high density lipoprotein cholesterol (HDL-C) levels. Obesity-related co-morbidities, such as metabolic syndrome (MetS) are also characterized by dyslipidaemia. Therefore, agents that favourably modulate LDL subclasses may be of clinical value in t…

obesitymedicine.medical_specialtyVery low-density lipoproteinLipoproteinslipid-lowering drugsanti-obesity drugslcsh:TX341-641030209 endocrinology & metabolismReview030204 cardiovascular system & hematologyOverweight03 medical and health scienceschemistry.chemical_compound0302 clinical medicineHigh-density lipoproteinInternal medicineHumansMedicineRisk factorDyslipidemiasMetabolic Syndromeobesity treatmentNutrition and Dieteticssmall dense low density lipoproteinbusiness.industryCholesterollipoproteinmedicine.disease3. Good healthEndocrinologychemistryCardiovascular DiseasesLow-density lipoproteinlipids (amino acids peptides and proteins)Metabolic syndromemedicine.symptombusinesslcsh:Nutrition. Foods and food supplyanti-obesity drugFood ScienceLipoproteinNutrients
researchProduct

Two‐year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5

2023

Background: The STEP 5 trial (NCT03693430) investigated once-weekly (OW) subcutaneous semaglutide 2.4 mg vs placebo for the treatment of overweight/obesity in adults over 2 years. Methods: Adults w ith B MI ≥ 3 0 k g/m2, or ≥27 kg/m2 and ≥ 1 weight-related comorbidity, without diabetes, were randomized 1:1 to semaglutide 2.4 mg OW or placebo for 104 weeks. Co-primary endpoints related to body weight (BW) changes. Control of eating questionnaire (CoEQ) was assessed in a subgroup from Canada/USA, with scores from 19 individual items grouped into 4 domains: craving control, craving for savory, craving for sweet, or positive mood. P values for exploratory CoEQ data are unadjusted for multiplici…

obesitysemaglutideNutrition and DieteticsEndocrinology Diabetes and MetabolismObesidadInvestigación médicaeating controlMedicine (miscellaneous)Settore MED/13 - Endocrinologiaobesity semaglutide craving control of eatingTratamiento médicoEndocrinologyGlucemiaSTEP 5Control glucémicoSettore MED/49 - Scienze Tecniche Dietetiche ApplicateObesity
researchProduct

Two-year Effect of Semaglutide 2.4 mg vs Placebo in Adults with Overweight or Obesity: STEP 5

2021

obesitysemaglutideSTEP 5Settore MED/49 - Scienze Tecniche Dietetiche ApplicateSettore MED/13 - Endocrinologia
researchProduct

Fighting the Consequences of the COVID-19 Pandemic: Mindfulness, Exercise, and Nutrition Practices to Reduce Eating Disorders and Promote Sustainabil…

2023

Over the past two years, the world’s population has been tested by the COVID-19 health emergency. This has changed population habits worldwide by encouraging a sedentary lifestyle and overnutrition. Isolation and reduction of social life, for most of the population, was mandatory but it quickly became a new lifestyle. Nowadays, we are encountering the consequences with an increase in nutritional associated disorders and conditions that cause illnesses in the general population. These disorders include diet excesses that lead to obesity and diet deficiencies and malnutrition which could rapidly lead to death. These eating disorders are very complex to manage because they become mental disord…

obesitytryptophan’s shuntplant-based dietRenewable Energy Sustainability and the EnvironmentMediterranean dietGeography Planning and DevelopmenthomeostasiBuilding and Constructionmalnutritionpsychological disordersManagement Monitoring Policy and Lawhealthy eating
researchProduct

Mettersi a dieta. Perchè, quando, come

2011

obesità dieta stile di vitàSettore MED/49 - Scienze Tecniche Dietetiche Applicate
researchProduct